| Literature DB >> 473113 |
S A Al-Ismail, D H Parry, C U Moisey, A L Bloom.
Abstract
An inhibitor to procoagulant factor VIII (FVIIIC) developed in a patient three years after palliative resection of a bronchogenic carcinoma. The inhibitor was not active against ristocetin cofactor but possibly had some activity against factor XI. It responded to immunosuppressive therapy. This is apparently the first reported association of carcinoma and factor VIII inhibitor.Entities:
Mesh：
Substances：
Year: 1979 PMID： 473113
Source DB: PubMed Journal: Thromb Haemost ISSN： 0340-6245 Impact factor: 5.249